Clinical Trial Update: Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer

View source ↗

Summary

The clinical trial evaluating infrared spectroscopy of breath volatile organic compounds in lung cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Breathe BioMedical Inc | Conditions: Lung Cancer, Non Small Cell Lung Cancer | Status: TERMINATED